MCL1 and central nervous system cancer: To understand whether MSC-AS1 was associated with TMZ resistance, we established the TMZ-resistant glioma cells, and the expression of drug-resistant marker proteins MCL-1 and MRP-1 was increased, and the cells showed higher cell viability in TMZ-resistant glioma cells, suggesting that the successful establishment of cell model.